Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP330798.RAGr4T3g_tj0Rg6t3pQJOquCBhYDVnWgOuPkpWngWVIPc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP330798.RAGr4T3g_tj0Rg6t3pQJOquCBhYDVnWgOuPkpWngWVIPc130_assertion type Assertion NP330798.RAGr4T3g_tj0Rg6t3pQJOquCBhYDVnWgOuPkpWngWVIPc130_head.
- NP330798.RAGr4T3g_tj0Rg6t3pQJOquCBhYDVnWgOuPkpWngWVIPc130_assertion wasGeneratedBy ECO_0000203 NP330798.RAGr4T3g_tj0Rg6t3pQJOquCBhYDVnWgOuPkpWngWVIPc130_provenance.
- NP330798.RAGr4T3g_tj0Rg6t3pQJOquCBhYDVnWgOuPkpWngWVIPc130_assertion wasDerivedFrom befree-2016 NP330798.RAGr4T3g_tj0Rg6t3pQJOquCBhYDVnWgOuPkpWngWVIPc130_provenance.
- NP330798.RAGr4T3g_tj0Rg6t3pQJOquCBhYDVnWgOuPkpWngWVIPc130_assertion SIO_000772 11566347 NP330798.RAGr4T3g_tj0Rg6t3pQJOquCBhYDVnWgOuPkpWngWVIPc130_provenance.
- NP330798.RAGr4T3g_tj0Rg6t3pQJOquCBhYDVnWgOuPkpWngWVIPc130_assertion evidence source_evidence_literature NP330798.RAGr4T3g_tj0Rg6t3pQJOquCBhYDVnWgOuPkpWngWVIPc130_provenance.
- NP330798.RAGr4T3g_tj0Rg6t3pQJOquCBhYDVnWgOuPkpWngWVIPc130_assertion description "[In addition to the t(3;21), other AML1 translocations have also been reported in therapy-related MDS and AML, particularly after treatment with topoisomerase II inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330798.RAGr4T3g_tj0Rg6t3pQJOquCBhYDVnWgOuPkpWngWVIPc130_provenance.